The number of opioid prescriptions filled by Medicare and Medicaid patients falls dramatically once states legalize marijuana, two major new studies show.
A group of hospitals in New Hampshire has pledged $50 million over five years to help fund opioid addiction treatment programs, a big boost in the state with the country’s third largest rate of drug overdoses.
Mice who were addicted to alcohol and were injected with human stem cells cut down their voluntary consumption by 80 to 90 percent in a new study conducted at the University of Chile.
The cost to first responders of the overdose-reversing drug naloxone has increased dramatically in recent years, and some U.S. Senators are now demanding that pharmaceutical companies explain their price hikes.
Narcan, a drug used to reverse opioid overdoses, is “like an EpiPen or CPR” and anyone who has a loved one at risk should carry it and be trained to use it, according to the U.S. Surgeon General.
President Trump’s recently announced opioid plan is drawing questions because it proposes treating all addicted federal inmates with Vivitrol – a non-generic drug manufactured by a single company – rather than allowing clinicians to select the form of medication-assisted treatment they think will work best in each particular case.
A bill making its way through the California legislature is designed to stop unscrupulous rehab centers and patient brokers from improperly signing patients up for private insurance and then bilking the insurance companies for inflated costs.
A pilot program in Virginia is offering free Uber rides to and from outpatient addiction centers and pharmacies, eliminating a barrier to treatment for poorer people in a rural area without mass-transit options.
The company that makes Suboxone and Sublocade has agreed to a $294 million deal for rights to a new drug that could help eliminate cravings for a wide variety of substances, including opioids, alcohol, and tobacco.
A bill that has a good chance of becoming law this year would allow doctors and hospitals to access a patient’s medical records involving alcohol and drug abuse without the patient’s consent.
Lawmakers in seven states – Kentucky, Minnesota, New Jersey, New York, Tennessee, Vermont, and West Virginia – are considering proposals to tax opioid drugs, in some cases specifically to raise funds for addiction treatment programs.
A non-psychoactive substance found in the marijuana plant has proven effective at reducing relapse tendencies in rats, suggesting the possibility of a new and effective treatment drug.
The Justice Department has announced an investigation into whether states are violating the Americans With Disabilities Act if they refuse to provide methadone, buprenorphine, or other anti-addiction drugs to people in state prisons.
As the U.S. Drug Enforcement Administration demands a sharp cutback in opioid production, many hospitals are reporting a “potentially life-threatening” shortage of standard painkillers, sometimes leading to postponement of surgeries as well as impromptu substitutions and a much greater likelihood of medical errors.
Marijuana and tobacco laced with insecticides such as Raid – known on the street as “Katie” or KD – are apparently highly addictive and leading to overdoses, according to first responders ... although the manufacturer of Raid denies this.
A pilot program that pairs pregnant women who have a substance use disorder with a recovery coach who has also experienced addiction while pregnant has been launched by a non-profit organization in Madison, Wisconsin.
The Missouri Senate has approved a plan to have the state’s Medicaid program pay for chiropractic treatment, in part as a way to keep people from taking opioid painkillers and becoming addicted.